These are the sources and citations used to research Telomerase inhibitor development for the treatment of malignant melanoma. This bibliography was generated on Cite This For Me on
In-text: (Bernardes de Jesus and Blasco, 2013)
Your Bibliography: Bernardes de Jesus, B. and Blasco, M., 2013. Telomerase at the intersection of cancer and aging. Trends in Genetics, 29(9), pp.513-520.
In-text: (Chettouh et al., 2013)
Your Bibliography: Chettouh, H., Fartoux, L., Aoudjehane, L., Wendum, D., Claperon, A., Chretien, Y., Rey, C., Scatton, O., Soubrane, O., Conti, F., Praz, F., Housset, C., Rosmorduc, O. and Desbois-Mouthon, C., 2013. Mitogenic Insulin Receptor-A Is Overexpressed in Human Hepatocellular Carcinoma due to EGFR-Mediated Dysregulation of RNA Splicing Factors. Cancer Research, 73(13), pp.3974-3986.
In-text: (Sanchez-Laorden, Jimenez-Cervantes and Garcia-Borron, 2006)
Your Bibliography: Sanchez-Laorden, B., Jimenez-Cervantes, C. and Garcia-Borron, J., 2006. Regulation of Human Melanocortin 1 Receptor Signaling and Trafficking by Thr-308 and Ser-316 and Its Alteration in Variant Alleles Associated with Red Hair and Skin Cancer. Journal of Biological Chemistry, 282(5), pp.3241-3251.
10,587 students joined last month!